Changes in DNA methylation in APOE and ACKR3 genes in multiple sclerosis patients and the relationship with their heavy metal blood levels-Reference-Cited by-同舟云学术

Changes in DNA methylation in APOE and ACKR3 genes in multiple sclerosis patients and the relationship with their heavy metal blood levels

Published:2021-12 Issue: Volume:87 Page:182-187
ISSN:0161-813X
Container-title:NeuroToxicology
language:en
Short-container-title:NeuroToxicology

Author:

Hasani Nourian Yazdan,Beh-Pajooh Abbas,Aliomrani Mehdi^ORCID,Amini Mohsen,Sahraian Mohammad A.,Hosseini Rohollah,Mohammadi Saeid,Ghahremani Mohammad H.

Publisher

Elsevier BV

Subject

Toxicology,General Neuroscience

Reference46 articles.

1. Protocatechuic acid mitigates cadmium-induced neurotoxicity in rats: role of oxidative stress, inflammation and apoptosis;Al Olayan;Sci. Total Environ.,2020

2. Blood concentrations of cadmium and lead in multiple sclerosis patients from Iran;Aliomrani;Iran. J. Pharm. Res.: IJPR,2016

3. Temporal trends in the incidence of multiple sclerosis: a systematic review;Alonso;Neurology,2008

4. Vitamin D and multiple sclerosis;Ascherio;Lancet Neurol.,2010

5. Arsenic and the epigenome: interindividual differences in arsenic metabolism related to distinct patterns of DNA methylation;Bailey;J. Biochem. Mol. Toxicol.,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Analysis of Alzheimer's Disease Mechanism Through DNA Methylation and Gene Expression Data;Afyon Kocatepe University Journal of Sciences and Engineering;2024-07-23

2. Relationship of Apolipoprotein E with Alzheimer’s Disease and Other Neurological Disorders: An Updated Review;Neuroscience;2023-03

3. From degenerative disease to malignant tumors: Insight to the function of ApoE;Biomedicine & Pharmacotherapy;2023-02

4. Expression levels and network analysis of inflammamiRs in peripheral blood mononuclear cells exposed to DDE “in vitro”;Environmental Toxicology and Pharmacology;2023-01

5. Evaluation of DNA methylation in BDNF, SLC6A4, NR3C1 and FKBP5 before and after treatment with selective serotonin-reuptake inhibitor in major depressive disorder;Epigenomics;2022-10